Morgan Stanley raises Insmed target to $60 on positive ASPEN data By Investing.com

Published on 29 May 2024 on Investing.com

On Tuesday, Morgan Stanley (NYSE:MS) updated its outlook for Insmed (NASDAQ:INSM) Incorporated...

Read the rest of the article

Start tracking your investments with Statfolio

We recently compiled a list of the 10 Best Performing NASDAQ Stocks in 2024. In this article, we ...

Insider Monkey · via Yahoo Finance 7 Oct 2024

We recently published a list of the 7 Best Performing Long Term Stocks in 2024. In this article, ...

Insider Monkey · via Yahoo Finance 30 Sep 2024

We recently compiled a list of the 12 Best Biotech Stocks To Invest In According To Hedge Funds. ...

Insider Monkey · via Yahoo Finance 20 Sep 2024

We recently published a list of 16 Best Mid Cap Growth Stocks To Buy Now. In this article, we are...

Insider Monkey · via Yahoo Finance 20 Sep 2024

On Wednesday, Wells Fargo maintained an Overweight rating on shares of Insmed (NASDAQ:INSM) ...

Investing.com 30 May 2024

On Tuesday, Morgan Stanley (NYSE:MS) updated its outlook for Insmed (NASDAQ:INSM) Incorporated...

Investing.com 29 May 2024

On Wednesday, Wolfe Research increased its price target on shares of Insmed (NASDAQ:INSM) ...

Investing.com 29 May 2024

U.S. stocks traded mixed this morning, with the Dow Jones index falling around 100 points on Tues...

Benzinga 29 May 2024

Shares of Applied DNA Sciences, Inc. APDN fell sharply during Tuesday's session after the company...

Benzinga 28 May 2024

On Tuesday, Insmed (NASDAQ:INSM) Incorporated (NASDAQ:INSM) received a reiterated Buy rating and ...

Investing.com 28 May 2024